The impact of COVID-19 on Diabetic Ketoacidosis patients

BACKGROUND AND AIM: Describe the prevalence/outcomes of Diabetic Ketoacidosis (DKA) patients comparing pre- (March–April 2019) and pandemic (March–April 2020) periods. METHODS: Retrospective cohort of admitted pandemic DKA/COVID-19+ patients comparing prevalence/outcomes to pre-pandemic DKA patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Faraz, Paladino, Lorenzo, Sinert, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736268/
https://www.ncbi.nlm.nih.gov/pubmed/35016042
http://dx.doi.org/10.1016/j.dsx.2022.102389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736268/
https://www.ncbi.nlm.nih.gov/pubmed/35016042
http://dx.doi.org/10.1016/j.dsx.2022.102389

Ejemplares similares